• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌筛查的成本效益分析:对卫生政策的影响

A cost-effectiveness analysis of cervical cancer screening: health policy implications.

作者信息

Gyrd-Hansen D, Hølund B, Andersen P

机构信息

Center for Health and Social Policy, Odense University, Denmark.

出版信息

Health Policy. 1995 Oct;34(1):35-51. doi: 10.1016/0168-8510(95)00720-d.

DOI:10.1016/0168-8510(95)00720-d
PMID:10151964
Abstract

This paper presents a framework for comparison of screening programme designs, based on efficiency and cost effectiveness criteria. The design parameters, such as choice of screening interval, which population segments to screen and expected participation rates in the selected population segments, are varied simultaneously. The costs and effects for a range of existing and hypothetical screening programmes against cervical cancer are estimated, using a mathematical simulation model. On the basis of these estimates average costs per life year and marginal costs per life year are calculated for a range of programmes. These calculations result in the definition of a range of inefficient programmes. Moreover, it is illustrated that the cost effectiveness of the efficient screening programmes decreases at an increasing rate as programmes are intensified either by way of shortening the screening interval or extending the target population segment to encompass the very young and/or the very old. The conclusion of this paper is that one should probably not extend screening programmes against cervical cancer beyond screening women in the age group 25-59 years every 4 years. In addition, increasing the participation rate of this group is a more cost effective way of increasing the number of life years gained, rather than extending the target group or decreasing the screening interval.

摘要

本文提出了一个基于效率和成本效益标准的筛查项目设计比较框架。设计参数,如筛查间隔的选择、筛查哪些人群以及所选人群的预期参与率,会同时变化。使用数学模拟模型估计了一系列现有和假设的宫颈癌筛查项目的成本和效果。基于这些估计,计算了一系列项目的每生命年平均成本和每生命年边际成本。这些计算结果确定了一系列低效项目。此外,研究表明,随着项目通过缩短筛查间隔或扩大目标人群范围以涵盖非常年轻和/或非常年老的人群而强化,有效筛查项目的成本效益会以越来越快的速度下降。本文的结论是,宫颈癌筛查项目可能不应超出每4年对25至59岁年龄组女性进行筛查的范围。此外,提高该群体的参与率是增加获得的生命年数的更具成本效益的方式,而不是扩大目标群体或缩短筛查间隔。

相似文献

1
A cost-effectiveness analysis of cervical cancer screening: health policy implications.宫颈癌筛查的成本效益分析:对卫生政策的影响
Health Policy. 1995 Oct;34(1):35-51. doi: 10.1016/0168-8510(95)00720-d.
2
[Costs and effects of alternative screening programs against cervical cancer].
Ugeskr Laeger. 1996 Aug 26;158(35):4912-5.
3
Cost-effective policies for cervical cancer screening. An international review.宫颈癌筛查的成本效益政策。一项国际综述。
Pharmacoeconomics. 1996 Mar;9(3):211-30. doi: 10.2165/00019053-199609030-00004.
4
Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.北欧国家癌症筛查对截至2017年的死亡、成本和生活质量的影响。
Acta Oncol. 1997;36 Suppl 9:1-60.
5
Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study.缩短英国国家医疗服务体系乳房筛查项目的筛查间隔或扩大年龄范围的成本效益:计算机模拟研究
BMJ. 1998 Aug 8;317(7155):376-9. doi: 10.1136/bmj.317.7155.376.
6
Assessment of cervical cancer screening and follow-up programs.
Public Health Rev. 1989;17(2-3):173-240.
7
8
Cost effectiveness of cervical cancer screening for the elderly.老年女性宫颈癌筛查的成本效益
Ann Intern Med. 1992 Sep 15;117(6):520-7. doi: 10.7326/0003-4819-117-6-520.
9
[Health economics analysis of cervical cancer screening].
Orv Hetil. 2003 Apr 13;144(15):713-7.
10
Cost-effectiveness of cervical cancer screening: comparison of screening policies.宫颈癌筛查的成本效益:筛查策略比较
J Natl Cancer Inst. 2002 Feb 6;94(3):193-204. doi: 10.1093/jnci/94.3.193.

引用本文的文献

1
Cervical cancer screening with AMIGAS: a cost-effectiveness analysis.采用 AMIGAS 进行宫颈癌筛查:成本效益分析。
Am J Prev Med. 2014 Jun;46(6):617-23. doi: 10.1016/j.amepre.2014.01.020.
2
The value of improving failures within a cervical cancer screening program: an example from Norway.改善宫颈癌筛查项目中漏诊情况的价值:来自挪威的一个例子。
Int J Cancer. 2014 Oct 15;135(8):1931-9. doi: 10.1002/ijc.28838. Epub 2014 Mar 20.
3
Modeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic model.
阿尔茨海默病的筛查、预防和延缓模型:早期决策分析模型。
BMC Med Inform Decis Mak. 2010 Apr 30;10:24. doi: 10.1186/1472-6947-10-24.
4
Calibration methods used in cancer simulation models and suggested reporting guidelines.癌症模拟模型中使用的校准方法及建议的报告指南。
Pharmacoeconomics. 2009;27(7):533-45. doi: 10.2165/11314830-000000000-00000.
5
Low risk of cervical cancer during a long period after negative screening in the Netherlands.在荷兰,筛查结果呈阴性后的很长一段时间内,宫颈癌风险较低。
Br J Cancer. 2003 Apr 7;88(7):1054-7. doi: 10.1038/sj.bjc.6600843.